Adimab Platform Technology. Adimab shall have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Patents directed to Adimab Platform Technology and all Adimab Platform Patents, all at its own expense.
Appears in 5 contracts
Sources: Assignment and License Agreement (Adagio Therapeutics, Inc.), Option and License Agreement, Option and License Agreement (Arsanis, Inc.)
Adimab Platform Technology. Adimab shall have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Program Patents directed to Adimab Platform Technology Improvements and all Adimab Platform Patents, all at its own expense.
Appears in 4 contracts
Sources: Collaboration Agreement (Leap Therapeutics, Inc.), Collaboration Agreement (Leap Therapeutics, Inc.), Collaboration Agreement (iTeos Therapeutics, Inc.)
Adimab Platform Technology. Adimab shall have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Patents directed to Adimab Platform Technology and Prosecute all Adimab Platform Patents, all at its own expense.
Appears in 2 contracts
Sources: Development and Option Agreement (Coherus BioSciences, Inc.), Development and Option Agreement (Surface Oncology, Inc.)
Adimab Platform Technology. Adimab shall have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Patents directed to Adimab Platform Technology Patents and all Patents within Adimab Platform PatentsOther Technology, all at its own expense.
Appears in 1 contract
Sources: Collaboration Agreement (Scholar Rock Holding Corp)
Adimab Platform Technology. Adimab shall will have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Program Patents directed to that Cover Adimab Platform Technology Improvements and Adimab CD3 Antibodies, and all Adimab Platform Patents, all at Adimab’s own expense and in its own expensesole discretion.
Appears in 1 contract
Adimab Platform Technology. Adimab shall will have the sole right (but not the obligation) to file, prosecute, maintain, defend and enforce all Program Patents directed to that claim Adimab Platform Technology Improvements and all Adimab Platform Patents, all at its own expense; provided, however, that Adimab shall not include in any such Program Patents any claims to (i) Program Inventions other than those that claim the Adimab Platform Technology or (ii) the Program Antibodies.
Appears in 1 contract
Sources: Collaboration Agreement (Adagio Therapeutics, Inc.)